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Abstract
Background: The opportunistic pathogen Klebsiella pneumoniae is one of the main causes of pediatric bacterial blood stream infec-
tions (BSI), which is complicated with sepsis and high mortality.
Objectives: To identify atypical Klebsiella species affecting a sample of infected neonates with low antimicrobial response.
Methods: Multidrug resistant blood cultures for Klebsiella from a Neonatal Service, were submitted to molecular identification by
sequencing analysis of 16S ribosomal RNA.
Results: The mean age of the newborns was 14.7±5.6 days. A total of 6 out of 8 cases were sepsis, 1 case of pneumonia, and 1 a catheter-
related infection. The molecular identification showed 3 cases of K. pneumoniae subsp. ozaenae, 2 of K. pneumoniae and K. variicola,
and 1 case of K. oxytoca. The highest antimicrobial resistance was against cephalosporins and Trimethoprim/sulfamethoxazole.
Conclusions: Klebsiella pneumoniae subsp. ozaenae was responsible for multidrug resistant strains of Klebsiella even in 37.5% of
cases. In our clinical setting, the use of Amikacin and carbapenems are still useful to treat neonatal infections by Klebsiella even
against K. variicola, which is the most resistant.
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1. Background
Pediatric bacterial Blood Stream Infections (BSI) are a
major cause of morbidity and mortality worldwide (1, 2).
In this regard, Enterobacteriaceae are the group with most
common agents causing BSI, among which, the genus Kleb-
siella is a major infectious agent (3). The opportunistic
pathogen Klebsiella pneumoniae has been classified into 3
phylogenetic groups: KpI; KpII-A/KpII-B, and KpIII (4), and
chromosomal class Aβ-lactamase blaSHV, blaOKP-A/blaOKP-
B, and blaLEN genes have been directly associated with
each of these groups, respectively (5). These groups cor-
respond to the species K. pneumonia (KpI), K. quasipneumo-
niae subspp. quasipneumoniae (KpII-A), K. quasipneumoniae
subspp. similipneumoniae (KpII-B), and K. variicola (KpIII)
(6). At present, K. oxytoca can cause infection in health-
care settings, with outbreaks of multidrug-resistant infec-
tion being increasingly reported in hospitalized patients
(7-12). Moreover, for pediatric population, infections due
to extended spectrum beta lactamase (ESBL)-resistant En-
terobacteriaceae are an emerging problem (13).
2. Objectives
The aim of this work was to identify atypical Klebsiella
species affecting a sample of infected neonates with sepsis,
catheter-related infection, or pneumonia.
3. Methods
3.1. Ethics Statement
The study was approved by the ethics and research
committee of the HMPMPS (code: 217B500402016058) and
we followed the mexican regulations of the general health
law in the field of research.
3.2. General Data
Information of blood cultures positive for Klebsiella
with a diagnosis of sepsis was retrieved from the epidemi-
ology service “Monica Pretelini Saenz” maternal-perinatal
hospital (HMPMPS), Health institute of the State of Mexico
(ISEM), Toluca, Mexico, from August to October 2016. Stan-
dardized collection of epidemiological data included age,
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clinical features, antimicrobial treatment, and final out-
come. All the information was managed on an Excel data
sheet.
At the neonatal intensive care unit (NICU) of our hospi-
tal, the diagnosis of sepsis was made if a patient exhibited
clinical manifestations and had any of the following cri-
teria: (1) white blood cell count (WBC) reduction to < 5×
109/L, platelet count (PLT) ≤ 100 × 109/L, and erythrocyte
sedimentation rate≥ 15 mm/h. The diagnosis of pneumo-
nia was based on unexplained worsening of the patient’s
respiratory status and a change in the quality of the respi-
ratory secretions supported by the chest x-ray, pulse oxime-
try, blood cultures, and Gram stain and culture of tracheal
aspirate. The suspicion of catheter-related bloodstream in-
fection (CRBSI) was based on clinical finding, fever, inflam-
mation, or purulence around the insertion site. In the 2
conditions, blood cultures had to be positive.
3.3. Culture and Identification
Blood-culture tubes were incubated at 35°C and in-
spected daily for signs of bacterial growth for 7 days. The
seeding was repeated 3 times during this period. All pos-
itive cultures were characterized by colony characteris-
tics, Gram stain, and standard biochemical tests. Rou-
tine subculture was undertaken at 24 hours, 48 hours,
and 7 days. Organisms were identified using Gram-
staining/microscopy, in-house biochemical testing, and
commercial biochemical-analytical profile-index kits. Sub-
cultures were performed with supplemented chocolate
agar and 5% sheep blood agar.
The MicoScan 4 (Beckman Coulter, Inc., USA) was used
to identify species of Klebsiella (all negative for hemolysis
in agar blood, positive for lactose and catalase, and neg-
ative for oxidase) and antimicrobial susceptibility. Drug
susceptibility testing was performed against Amikacin,
Ampicillin, Cefepime, Ceftriaxone, Cefotaxime, Cefote-
tam, Cefuroxime, Ciprofloxacin, Ertapetem, Gentamicin,
Imipenem, Levofloxacin, Meropenem, Moxifloxacin, Tetra-
cycline, Tigecycline, and Trimethoprim/Sulfamethoxazole,
reporting the minimum inhibitory concentration (MIC)
for each of the isolates. In this study, multidrug resistance
was defined as simultaneous resistance to 2 or more drugs
of different classes of antimicrobial agents.
3.4. Molecular Identification
The samples were transported to the Laboratory of Mi-
crobiology of the faculty of medicine, autonomous univer-
sity of the state of Mexico (UAEMEx), in enriched media
such as blood agar or brain heart infusion (BHI) broth. To
obtain biomass, the bacteria were inoculated in the BHI
medium and incubated at 37°C for 3 days. Isolated strains
were extracted with DNA, according to the Wizard® Ge-
nomic DNA purification kit (Promega A1120) protocol. The
8 strains previously classified as K. pneumoniae were char-
acterized by 16S rRNA (rrs) gene sequencing. For this proce-
dure, 2 sets of universal primers were used: 27f 5’-AGA GTT
TGA TCM TGG CTC AG-3’ and 1492r: 5’- TAC GGY TAC CTT GTT
ACG ACT T-3’.
Polymerase chain reaction (PCR) was performed using
Taq DNA polymerase in storage buffer B Bioline® Brand
(BIO 21105). The conditions of the thermal cycle were
as follows: a pre-denaturation cycle of 5 min (94°C); de-
naturation for 30 seconds (94°C); coupling for 20 sec-
onds (52°C), and elongation for 1.5 minutes (72°C); 34 cy-
cles were repeated and then a post-elongation cycle of 7
minutes (72°C) was performed. The amplified products
were purified using the Amicon ultra filter kit (Millipore
UFC901008) and checked for presence and quality on 1%
agarose gel. The 16S ribosomal RNA amplification prod-
ucts were sent to the sequencing service of macrogen se-
quencing service (Maryland, USA). The sequences obtained
were assembled and corrected using the Chromas Pro ver-
sion 1.5 program. The sequences obtained were compared
to the sequences validated and deposited in the GenBank
databases of the national center for biotechnology infor-
mation (NCBI) through the BLAST program. Nucleotide se-
quence accession numbers were the following: 1, KY711154.1;
2, KY711153.1; 3, KY711152.1; 4, KY711151.1; 5, KY711150.1; 6,
KY711149.1; 7, KY711148.1 and 8, KY711147.1.
4. Results
The mean age of the newborns (2 females and 6 males)
was of 14.7± 5.6 days. At the moment of identification by
using the 16S rRNA sequence, 5 patients were discharged
from the hospital and 3 remained hospitalized. In total,
6 of the 8 cases were sepsis and there was 1 case of pneu-
monia and 1 attributed to an infection at the catheter-
insertion site. MicroScan 4 reported the identification of K.
pneumoniae from 7 isolates and only 1 of K. spp. In contrast,
molecular identification revealed 1 case of K. oxytoca, 2 of K.
variicola, 2 of K. pneumoniae, and 3 cases of K. pneumoniae
subspp. ozaenae. A list of isolates and molecular identifica-
tion is provided in Table 1.
From the antibiogram (Table 2), we can see that, fortu-
nately, there were no ESBL; however, there was resistance to
cephalosporins, Trimethoprim/Sulfamethoxazole and, in
3rd place, to quinolones. Trying to define more objective
criteria to determine the bacterial aggressiveness, for each
bacterium the antibiotic sensibilities (S) were divided be-
tween the antibiotic resistances (R) = S/R. Subsequently a
mean was obtained for the same type cultures, obtaining
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Table 1. General Data of the Strains with the MicroScan4 and Molecular Identification
Patient Gender Age (Days) Evolution Clinical Infection Identification
MicroScan4
Blood Culture
Key
Molecular
Identification
Length Fragment
(pb)
Similarity %
Strain
1 M 10 HD Sepsis Klebsiella
pneumoniae
H1157 Klebsiella
pneumoniae subsp.
ozaenae, 1273pb
99, ATCC 11296
2 F 19 HD Catheter-related
infection
Klebsiella
pneumoniae
H821 Klebsiella variicola,
1320pb
98, F2R9
3 M 9 HD Sepsis Klebsiella
pneumoniae
H814 Klebsiella
pneumonia, 1362pb
99, DSM 30104
4 M 15 HD Sepsis Klebsiella
pneumoniae
H1064 Klebsiella
pneumoniae subsp.
ozaenae, 1318pb
98, ATCC 11296
5 M 21 HD Pneumonia Klebsiella sp. H793 Klebsiella oxytoca,
1207pb
99, ATCC 13182
6 M 9 SH Sepsis Klebsiella
pneumoniae
H776 Klebsiella variicola,
1206pb
100, LX3
7 F 23 SH Sepsis Klebsiella
pneumoniae
H1078 Klebsiella
pneumonia, 1213pb
100, DSM 30104
8 M 12 SH Sepsis Klebsiella
pneumoniae
H759 Klebsiella
pneumoniae subsp.
Ozaenae, 1357pb
99, ATCC 11296
Abbreviations: HD, hospital discharge (improvement); SH, still hospitalized.
the next S/R values: K. oxytoca: 3, K. pneumoniae subsp. oza-
enae: 0.643, K. pneumoniae: 0.607, and K. variicola: 0.452.
5. Discussion
Tariq and Rasool published that, in cases of culture-
proven sepsis, among Enterobacteriaceae, 31.82% were K.
species (K. pneumonia and K. oxytoca) (14). This becomes
more relevant because K. pneumoniae, K. variicola, and K.
quasipneumoniae are difficult to differentiate phenotypi-
cally, leading to misinterpretation of their infection preva-
lence (6, 15, 16). In fact, to our knowledge, there is no
biochemical test capable of differentiating these 3 Kleb-
siella species concomitantly during routines in clinical mi-
crobiology laboratories. A very important issue to take
into account is that Klebsiella singaporensis is a junior het-
erotypic synonym of K. variicola and some studies, even
with the technique we used, still report the first as a differ-
ent species (17). Even more, K. oxytoca is known to have a
similar antimicrobial resistance profile to that of K. pneu-
monia.
Surprisingly in this survey the first was even less re-
sistant to the antibiotics usually indicated in the Neona-
tal Service. Contrastingly, K. variicola seems to be the most
dangerous strain as one of the registered cases showed re-
sistance against 9 antibiotics, and probably more, how-
ever, in the moment of the analysis, the equipment ran out
of reagents. With the available information the SR ratio re-
flected the severity of K. variicola in this exercise of neona-
tal infections. Our results illustrates the possibility that as
K. variicola was very recently described as a new bacterial
species and is very closely related to K. pneumoniae, it might
be the case that some isolates, which were initially classi-
fied as K. pneumoniae, were actually K. variicola (18), being
the cases of greatest suspicion to those with higher mor-
tality (19).
Research concerning antibiotic resistance profiles of
Klebsiella isolates are diverse, for example, Vasaikar et
al. reported, in South Africa, high antibiotic resistance
in decreasing order to penicillins, cephalosporins, fo-
late pathway inhibitors, monobactams, and aminoglyco-
sides. A percentage of low resistance was observed in
carbapenems, aminoglycosides (only Amikacin), glycylcy-
clines (Tigecycline), cephamycins (Cefoxitin), quinolone
(Levofloxacin), phosphonic acids (Fosfomycin), antipseu-
domonal penicillins + β-lactamase inhibitor (pip/tazo),
and fluoroquinolones (Ciprofloxacin), which can be con-
sidered for treatment of Klebsiella species (3). In contrast,
in Mexico, the option of quinolones would not be so use-
ful.
Although our sample is low, in a previous work done
by Dong et al., (20), from a sample of 96 cases of neona-
tal sepsis, 19 were Gram-negative bacteria and only 10
Jundishapur J Microbiol. In Press(In Press):e62393. 3
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Table 2. Antibiograms
Patient
Antibiotic 1 2 3 4 5 6 7 8 % Resistancea
Amikacin NE S S S R S S S 14.28
Ampicilin NE R R R R R R R 100
Cefepime NE R WR R WR R R R 100
Ceftriaxone NE R R R R R R R 100
Cefotaxime NE R R R WR R R R 100
Cefotetam NE WR WR WR S WR WR WR 0
Cefuroxime NE R R R WR R R R 100
Ciprofloxacin NE R S R S R R R 28.57
Ertapetem NE WR WR WR S WR WR WR 0
Gentamicin NE R R R WR R R R 100
Imipenem NE S S S S S S S 0
Levofloxacin NE R S S S S R S 28.57
Meropenem NE S S S S S S S 0
Moxifloxacin NE WR R WR WR WR S S 33.33
Tetracycline NE WR WR WR S WR WR WR 0
Tigecycline NE WR WR WR S WR WR WR 0
Trimethoprim/sulfamethoxazole NE R R WR S WR WR WR 66.66
Total tests 12 12 11 12 11 12 12
Sensitivity 3 5 4 9 4 4 5
Resistance 9 7 7 3 7 8 7
S/R 0.33 0.71 0.57 3.00 0.57 0.50 0.71
Abbreviations: NE, Non evaluated; R, resistant; S, Sensitive; WR, without reactive.
a Taking into account only those samples with report of antibiogram.
cases were K. pneumoniae subsp., which exhibited full re-
sistance (100%) to amoxicillin, amoxicillin/clavulanate, ce-
fepime, cefoxitin, ceftazidime, cefotaxime, cefuroxime,
and piperacillin, a 70.0% cephalothin resistance rate, and
no resistance to amikacin, meropenem, or netilmicin. Re-
sistance to carbapenems with varying prevalence has been
reported at sites worldwide (21). Thus, screening Enter-
obacteriaceae for ESBL production is essential for better
antibiotic selection and preventing its further emergence
and spread. In our study, fortunately, there was no case
of carbapenemase-producing isolation. However, our find-
ings did not consider other types of Enterobacteriaceae.
Finally, talking about the strain identification tech-
niques, nowadays, PCR diagnosis can confirm the pres-
ence or absence of bacterial genomic DNA, giving a diag-
nosis to the clinician in a few hours (22). Furthermore,
molecular tests based on multiplex real-time quantitative
PCR (23) could be more useful in cases of neonatal sep-
sis. However, this technique is very expensive for most of
the general hospitals and not affordable for the health sys-
tems of many low income countries. In the case of Mexico,
a medium income country, most of the samples of mul-
tidrug resistance are not processed by failures in reagent
supply or lack of specialized laboratories in all the Mexi-
can states. This study is limited by its retrospective obser-
vational design, and nonsystematic sampling of hospital
staff may underestimate the true burden of BSI. Despite
the limitations, we have determined through molecular
techniques that Klebsiella species are scarcely known and
hardly reported in Latin America.
A future action should be the design of antibiotic-
decision flowcharts based on the resistance and clinical
parameters as well as studies available in general hospi-
tals. It remains pending the use of new alternatives to treat
neonatal infections. For example, our group has explored
the use of triazoles obtained by “Via click” against Candida
albicans (24), however, this type of compounds are far from
being clinically approved yet. Another point of view has
been the re-evaluation of known antibiotics such as col-
istin (25).
6. Conclusion
First, within our clinical setting of Neonatal care, mul-
tidrug resistant strains of Klebsiella can be attributed to
K. pneumoniae subsp. ozaenae even in 37.5% of cases. Sec-
ond, as a result of this study, we conclude that in our clin-
ical setting, the use of Amikacin and carbapenems, are
still useful to treat neonatal infections by Klebsiella even
against K. variicola, which is the most resistant. Two main
4 Jundishapur J Microbiol. In Press(In Press):e62393.
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future actions should be implemented a, ensure the cor-
rect equipment of state laboratories and their adequate
provision of reagents and b, the design of antibiotics de-
cision flowcharts based on the resistance, clinical parame-
ters, and studies available in general hospitals.
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